High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments

Optimal management of central nervous system (CNS) infiltration is a key remaining challenge in delivering precision therapy for childhood acute lymphoblastic leukemia (ALL).[1][1] Most CNS relapses occur in children without high-risk features, and minimal residual disease (MRD) does not reliably